CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6 enrolled
Drug / intervention
Proton Beam Radiation Therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02204761
NCT02204761N/ACompleted
CompareCT.gov

Definitive Re-irradiation With Proton Beam Radiotherapy for Patients With Recurrent Thoracic Cancers

University of Washington·interventional·Posted Jul 30, 2014·Updated Nov 20, 2018

In Brief

A clinical study evaluating Proton Beam Radiation Therapy for Metastatic Malignant Neoplasm in the Lung and 2 related conditions. Completed, enrolled 6 participants across 2 sites.

Detailed Summary

This pilot clinical trial studies proton beam radiation therapy in treating patients with thoracic cancer that has come back and have received prior radiation therapy. Proton beam radiation therapy uses high energy protons to kill tumor cells and may cause less damage to normal tissue.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMetastatic Malignant Neoplasm in the Lung, Recurrent Disease, Thoracic Neoplasm
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 30, 2014
Enrollment StartSep 9, 2014
Primary CompletionSep 7, 2017
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 11.9 years ago

Interventions

Proton Beam Radiation Therapyradiation

Undergo proton beam re-irradiation therapy